Sign in

CIK 0001875558

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Nuvectis Pharma, Inc.

Sign in to watch
Ticker
NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
862405608
Phone
+1 360-837-7232
Business address
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-14 BENTSUR RON Chairman & CEO Purchase +8,000 $5.88 $47K 2,814,459
2022-02-10 BENTSUR RON Chairman & CEO Purchase +8,500 $6.34 $54K 2,806,459
2022-02-07 Poradosu Enrique Chief Science & Business Off Purchase +800 $3.88 $3K 1,197,649
2022-02-07 Shemesh Shay Chief Development Officer Purchase +846 $3.47 $3K 1,179,615
2022-02-07 BENTSUR RON Chairman & CEO Purchase +14,000 $3.93 $55K 2,791,959
2022-02-07 BENTSUR RON Chairman & CEO Purchase +6,000 $8.25 $50K 2,797,959
2022-02-04 Poradosu Enrique Chief Science & Business Off Purchase +3,800 $3.35 $13K 1,196,849
2022-02-04 Shemesh Shay Chief Development Officer Purchase +2,100 $3.38 $7K 1,178,769
2022-02-04 BENTSUR RON Chairman & CEO Purchase +200,000 $5.00 $1.0M 2,765,459
2022-02-04 BENTSUR RON Chairman & CEO Purchase +12,500 $3.89 $49K 2,777,959

Page 10 of 10 · 190 trades